FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.Read MoreLung Cancer, Drugs (Pharmaceuticals), Amgen Inc, Food and Drug Administration, Clinical TrialsNYT > Health